Counterpath Corp
CPAH
CPAH was delisted on the 26th of February, 2021.
8 hedge funds and large institutions have $3.21M invested in Counterpath Corp in 2013 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
60% more funds holding
Funds holding: 5 → 8 (+3)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
22% less capital invested
Capital invested by funds: $4.1M → $3.21M (-$894K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
+$27.4K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$4.43K |
| 3 |
U
UBS
Zurich,
Switzerland
|
+$3.39K |
| 4 |
Morgan Stanley
New York
|
+$655 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.17K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Fidelity Investments
Boston,
Massachusetts
| $3.12M | – | – | – |
|
|
CA
2
Commerzbank Aktiengesellschaft
Frankfurt,
Germany
| $31K | – | – | – |
|
|
VKH
3
Virtu KCG Holdings
New York
| $22K | +$27.4K | +2,095 | New |
|
|
4
Citadel Advisors
Miami,
Florida
| $18K | +$4.43K | +338 | +25% |
|
5
Royal Bank of Canada
Toronto,
Ontario, Canada
| $16K | – | – | – |
|
|
U
6
UBS
Zurich,
Switzerland
| $3K | +$3.39K | +259 | New |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $1K | -$1.17K | -89 | -63% |
|
|
8
Morgan Stanley
New York
| $1K | +$655 | +50 | New |
|
CPAH Hedge Fund Activity: Q4 2013 in Review
8 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Counterpath Corp (CPAH) for Q4 2013, worth a combined $3.21M — down 22% from $4.1M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new CPAH positions and 0 closed out — a net gain of 3 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Virtu KCG Holdings, opening a new position worth an estimated $27.4K. The largest seller was Tower Research Capital (TRC), cutting an estimated $1.17K.
- 8 institutional investors held Counterpath Corp (CPAH) as of Q4 2013, up from 5 in Q3 2013.
- Funds reported $3.21M of Counterpath Corp stock for Q4 2013, down 22% quarter-over-quarter.
- 3 funds opened new Counterpath Corp positions in Q4 2013 and 0 closed out, a net change of +3 holders.
- The largest Counterpath Corp buyer in Q4 2013 was Virtu KCG Holdings, an estimated $27.4K added.
- The largest Counterpath Corp seller in Q4 2013 was Tower Research Capital (TRC), an estimated $1.17K sold.
Based on aggregated 13F filings for Q4 2013.